The 2026 annual meeting of the American Urogynecologic Society (AUGS) is just a few weeks away. From October 4 through October 7, in Denver, Colorado, the 2026 AUGS Annual Meeting is four days of networking opportunities, educational sessions, and research presentations, all for health care professionals dedicated to advancing urogynecology and reconstructive pelvic surgery.

Today, we have a preview of key clinical sessions currently schedule to take place at the 2026 AUGS annual meeting. All times and dates are accurate as of September 2, 2026. The first day of the conference, October 4, has only a handful of planned events and is primarily for attendee and speaker services, program directors, and career development events. For the complete look at the meeting agenda, as well as the most up-to-date scheduling information, view the event calendar on the official website.

Clinical Sessions at AUGS 2026 Annual Meeting

Monday, October 5

  • Beyond the Tip of the Iceberg: A Comprehensive Approach to Menopause Transitions
    • 8:00 AM – 11:30 AM
    • Description: This pre-conference workshop features discussions on topics including the musculoskeletal syndrome of menopause and beyond, genitourinary syndrome of menopause and associated sexual dysfunction, and more.
  • Integrating Sexual Function into Pelvic Care: Evidence-Based Approaches
    • 8:00 AM – 11:30 AM
    • Description: This pre-conference workshop features discussions on topics including sexual function as a core component of pelvic care, sexual function in urogynecologic care, and more.
  • Multidisciplinary Pelvic Floor Care – Ins and Outs of an Integrated Program
    • 8:00 AM – 11:30 AM
    • Description: This pre-conference workshop features discussions on topics including multidisciplinary approaches to pelvic floor disorders, a case-based discussion on different modalities of radiologic imaging, and more.
  • General Session 1: After the Repair
    • 1:00 PM – 3:00 PM
    • Description: This session is set to discuss topics including retropubic versus single-incision sling during sarcocolpopexy, factors associated with surgical failure of three VPP approaches across five years, among others.
  • General Session 2: Outcomes Patients Feel
    • 3:30 PM – 5:10 PM
    • Description: This session features topics including GLP-1 therapy outcomes, a trial on short-term oral magnesium for postoperative pain, chronic maternal pelvic morbidity, and more.

Tuesday, October 6

  • General Session 3: Challenging the Clinical Status Quo
    • 8:00 AM – 10:00 AM
    • Description: This session will discuss topics including AI-generated urogynecology counseling, reduced UTIs with intermittent catheter drainage following pelvic floor surgery, vaginal tissue response to estrogen assessed by optical coherence tomography, and more.
  • Concurrent Sessions: Restoring Form and Function, Rethinking Refractory LUTS, and What’s Next
    • 10:25 AM – 12:00 PM
    • Description: Three separate sessions are set to take place at the same time. Restoring Form and Function includes discussions on tissue-engineered neovagina for vaginal agenesis, the vaginal laxity scale, lessons learned from difficult cases, and more. The Rethinking Refractory LUTS session features discussions on a RCT of intradetrusor onabotulinumtoxinA UTI prophylaxis, physical activity and fall risk in older women with UUI, improved care for urinary incontinence, and more. For the What’s Next session, discussions anticipated to take place include sleep-related quality-of-life improvements for patients with nocturia, a wearable tibial nerve neuromodulation system, and more.
  • General Session 4: What’s Shaping Our Field
    • 1:00 PM – 2:55 PM
    • Description: This session will feature discussions on nonsurgical options for urinary incontinence in women, translational and clinical areas of study advancing pelvic floor research, among others. 
  • General Session 5: Surgical Strategies 2.0
    • 3:15 PM – 5:05 PM
    • Description: Topics set to be discussed during this session include if prophylactic antibiotics are necessary for urethral bulking, urinary incontinence improvement after midurethral sling, the efficacy of polyacrylamide hydrogel versus midurethral sling during prolapse repair, and more.

Wednesday, October 7

  • Concurrent Rapid Fire Sessions: The Patient Voice in LUTS Care, What Drives Success in Prolapse and Incontinence Surgery, Advancing Function, Quality, and Value at All Ages
    • 8:00 AM – 9:05 AM
    • Description: Three concurrent rapid fire sessions are set to take place Wednesday morning. Topics in The Patient Voice in LUTS Care include system-level diagnostic stewardship and antibiotic prescribing for UTI, identifying modifiable barriers to urogynecologic care, and more. Topics in What Drives Success in Prolapse and Incontinence Surgery include pectopexy versus sacrocolpopexy for mesh-augmented apical suspension, retreatment outcomes after sacrocolpopexy, and others. The Advancing Function, Quality, and Value at All Ages session includes discussion on trends in minimally invasive overactive bladder therapy use among older adults, diagnostic evaluation of enlarged genital hiatus, and others.
  • General Session 6: Tough Cases Tough Conversations
    • 9:20 AM – 10:50 AM
    • Description: The presentations during this session focus on topics including complex recurrent incontinence, discussions on disability, and more.
  • Concurrent Sessions: Risk Readiness and Results, Enduring the Impact of Childbirth, Mechanisms that Matter
    • 11:15 AM – 12:30 PM
    • Description: Three concurrent sessions are set to take place during this time. The session, Risk Readiness and Results, includes discussions on surgery for pelvic floor disorders, reoperation after mid-urethral sling, and more. The session Enduring the Impact of Childbirth will discuss antibiotic choice and functional morbidity after obstetric anal sphincter injury, the effect of vaginal estrogen on sexual function after OASI, and more. The third session, Mechanisms that Matter, will discuss how pelvic floor muscle stem cells drive protective adaptations during pregnancy, raman spectroscopy for in vivo optical analysis of human vaginal tissue, among others.
  • General Session 7: Continence, Consensus, and Career Development
    • 1:30 PM – 3:30 PM
    • Description: This session features presentations on topics that include an update on AUGS recommended guidelines for privileges in POP and UI surgery, trends in stress urinary incontinence procedures since 2000, predictors of hospitalization or sepsis after outpatient urinary tract infection, and more.

Check out our latest obstetrics and gynecology content and sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.